best glp 1 for menopause GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities Peptides for menopause weight loss:

The FDA reports include nausea, vomiting, diarrhea, abdominal pain, constipation, injection site reactions, and more severe outcomes including pancreatitis requiring hospitalization, gallbladder disease, severe hypoglycemia, and acute kidney injury

The Effects of Dipeptidyl Peptidase 4 Inhibitors on Renal Function in Patients with Type 2 Diabetes Mellitus

Tributyrin goes in next if baseline butyrate producers come back depleted on sequencing

If your compounded pharmacy offers volume discounts , calculate whether you can realistically use the extra vials before they expire

doi:10.1038/s41366-025-01859-6 51

doi: 10.1007/s40263-016-0361-4